byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan
byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan
byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic
by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic
by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous
by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous
byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi
by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi
byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance
byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance
by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas
by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas
by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found."
byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found."